The deals with nine companies mean the MFN policy's reach now covers 89% of the branded US pharmaceutical market, according ...

The deals with nine companies mean the MFN policy's reach now covers 89% of the branded US pharmaceutical market, according ...

With approval to treat essential thrombocytopenia, Besremi, already indicated to treat polycythemia vera, will face off ...

An exhibit booth display and brochure at the American Psychiatric Association annual meeting suggested the investigational ...

Nutrition, health and wellness product direct seller says CEO Stephan Gratziani will leave on Oct. 31 while continuing as a ...

Cosmetic regulators from across the globe came together and agreed on general principles for minimizing barriers to trade at ...

The FDA said Boston Scientific is removing its Imager II Angiographic Catheters because a manufacturing issue could cause the catheter tip to degrade and detach during use. The company has also ...

Moderna's shift in regulatory strategy produced a massive data set to respond to vaccine safety critics, as illustrated in ...

Narver, a former assistant director in the Justice Department’s Consumer Protection Branch, became director of the Office of ...

A positive outcome from the project could also lay the foundation for the future expansion of Egypt-based Minapharm's vaccine ...

Brand names for medicines in Turkey will be subject to new guidelines from January 2027, with the regulator emphasizing that ...

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical ...